BioLineRx (BLRX) Total Debt Growth (5y) (2020 - 2025)
BioLineRx (BLRX) Total Debt Growth (5y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
BioLineRx |
227.63 Mn |
211.90 Mn |
154,000.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
8.92% |
| Sep 30, 2025 |
9.09% |
| Jun 30, 2025 |
9.25% |
| Mar 31, 2025 |
9.42% |
| Dec 31, 2024 |
9.61% |
| Sep 30, 2024 |
24.82% |
| Jun 30, 2024 |
26.81% |
| Mar 31, 2024 |
1.65% |
| Dec 31, 2023 |
2.28% |
| Sep 30, 2023 |
166.39% |
| Jun 30, 2023 |
154.22% |
| Mar 31, 2023 |
140.93% |
| Dec 31, 2022 |
109.83% |
| Sep 30, 2022 |
119.42% |
| Jun 30, 2022 |
37.92% |
| Mar 31, 2022 |
53.00% |
| Dec 31, 2021 |
51.72% |
| Sep 30, 2021 |
67.39% |
| Jun 30, 2021 |
71.25% |
| Mar 31, 2021 |
74.05% |
